Superior Planning, LLC’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Superior Planning, LLC’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.35K	Buy	+135	New	+$4.83K	﹤0.01%	1182

Other funds holding TEVA

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $20.7B AUM 58.31% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

Superior Planning, LLC's TEVA Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026: 135 shares worth $5.35K. The stake represents ﹤0.01% of the portfolio and ranks #1182 among its holdings.

401 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

Superior Planning, LLC held 135 shares of Teva Pharmaceutical Industries Limited worth $5.35K as of Q3 2026.
Teva Pharmaceutical Industries Limited was a new Superior Planning, LLC position in Q3 2026.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1182 holding.
401 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.